Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
UCBCares: Providing Dedicated Patient Support
Clinical studies at UCB: How are medicines made and tested?
Twitter Feed
-
Find out how UCB is leveraging its laboratory infrastructure and expertise to help to tackle the ongoing #COVID19 pandemic. https://t.co/bizgtqXt7i https://t.co/BbkbAkGXeM
— UCB News (@ucb_news) 29.05.2020 -
In just two weeks, our colleagues in Braine worked tirelessly to finish setting up our new diagnostic testing labs for testing of SARS-CoV-2 samples. Find out more: https://t.co/bizgtqXt7i https://t.co/wOmyhBr3O9
— UCB News (@ucb_news) 29.05.2020 -
This #PSPAwarenessMonth we’ve been raising awareness of #ProgressiveSupranuclearPalsy (PSP); a rare, neurodegenerative brain disorder. PSP has a devastating impact on patients and their loved ones. Our thoughts are with people and caregivers affected by t
— UCB News (@ucb_news) 26.05.2020
Instagram Feed
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
